Stock information

General information

Total Shares Issued (as of End of December 2020) 32,890,046
Designated Sponsor/Market Maker: Oddo Seydler Bank AG
Reuters: MORG.DE
Bloomberg MOR:GR
Paying Agent Deutsche Bank AG
Global Securities Services
lssuer Services / Post IPO Seruices
Taunusanlage 12
60325 Frankfurt am Main

listing in Germany

Stock Exchange: Frankfurt, Germany (Prime Standard)
Index: MDAX & TecDAX
SE Code: MOR
Security Code Number: 663 200
ISIN (International Security Identification Number): DE0006632003
1st Trading Day: March 9, 1999 (Neuer Markt)

Listing in the u.s.

Stock Exchange: Nasdaq
SE Code: MOR
CUSIP: 617760202
1st Trading Day: April 19, 2018
Security Paper: American Depositary Shares (ADS)
Ratio: 4 ADS = 1 Ordinary Share


Stock charts

Share price performance

The 2019 trading year turned out to be an exceptional year, despite the relatively challenging political and economic environment. Germany’s leading DAX index gained more than 25 % for the full year, while the MDAX rose even higher, gaining more than 30 %. Concerns about a downturn in the global economy, the trade dispute between the U.S. and China, and uncertainties surrounding Brexit were not enough to dampen the favorable performance. The Dow Jones also ended the year on a positive note, with a gain of 22 %. Biotechnology stocks benefited from this trend, reflected by the gain in the Nasdaq Biotech Index of 24 % over the prior year.

MorphoSys AG shares have been trading on the Frankfurt Stock Exchange since 1999. In April 2018, MorphoSys issued American Depositary Shares (ADSs) based on MorphoSys’ common stock and began trading on the U.S. Nasdaq exchange. The Company’s ticker symbol is “MOR” on both exchanges. MorphoSys’ shares began the reporting year on the Frankfurt Stock Exchange at a price of € 88.95. After maneuvering a relatively volatile first half-year, the shares gained considerable momentum in July 2019 and broke through the € 100 threshold on July 19, 2019. The shares then began a year-end rally starting in mid-November and reached their high for the year on December 16, 2019 at € 129.90. The shares closed the reporting year at € 126.80, recording a gain of 43 %.

Liquidity and Index Membership

The average daily trading volume in MorphoSys shares across all regulated trading platforms grew by approximately 14 % in 2019 over the prior year and amounted to € 25.6 million (2018: € 22.5 million). The average daily trading volume on the TecDAX and MDAX indices also saw a rise of respectively 82 % and 19 %. At the end of 2019, MorphoSys ranked 9th in the TecDAX in terms of market capitalization* (2018: 10th) and 11th in terms of trading volume (2018: 14th). In the MDAX, MorphoSys shares ranked 55th in terms of market capitalization (2018: 59th) and 57th in terms of trading volume (2018: 65th; the rank refers to DAX (30) and MDAX (60) companies).

On alternative trading platforms (“dark pools”), the average daily trading volume in MorphoSys shares amounted to approximately 196,000 shares, valued at € 19.1 million in 2019 (2018: approximately 173,000 shares valued at € 16.2 million), representing a year-on-year increase of around 17 %.


Key data for the MorphoSys Share (As of December 31)

  2019 2018 2017 2016 2015
Total stockholders´ equity (in million €) 394.7 488.4 358.7 415.5 362.7
Number of shares issued (number) 31,957,958 31,839,572 29,420,785 29,159,770 26,537,682
Market capitalization (in million €) 4,052 2,832 2,253 1,422 1,530
Closing price in € (Xetra) 126.80 88.95 76,58 48.75 57.65
Average daily trading volume (in million €) 25.6 22.5 15,6 9.7 14.9
Average daily trading volume (in % of common stock) 0.81 0.77 0,83 0.78 0.87

Recent voting rights notifications

Sorry, but there are no pressreleases available for the selected year.


Institution Contact
Barclays Ms. Emily Field
Berenberg N.N.
Bloomberg Intelligence Ms. Cinney Zhang
Bryan Garnier Mr. Victor Floc’h
Citi Mr. Vineet Agrawal
Commerzbank Mr. Daniel Wendorff
Deutsche Bank Mr. Rajan Sharma
EQUI.TS Mr. Thomas Schießle
Frankfurt Main Research AG Mr. Christian Ehmann
Goldman Sachs Mr. Graig Suvannavejh       
Guggenheim Securities, LLC Mr. Etzer Darout
HSBC Bank Mr. Steve McGarry
Independent Research GmbH Mr. Tobias Gottschalt
JMP Securities Mr. Jason Butler
J.P.Morgan Cazenove Mr. James Gordon
Kempen & Co. Ms. Suzanne van Voorthuizen
Landesbank Baden-Württemberg Mr. Timo Kürschner
Leerink Mr. Geoffrey Porges
Mainfirst Mr. Marcus Wieprecht
Royal Bank of Canada Ms. Zoe Karamanoli


Any opinions, forecasts, estimates, projections or predictions regarding MorphoSys’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections or predictions of MorphoSys or its management. By providing the names of the analysts or certain information from them, MorphoSys does not imply its endorsement of or concurrence with their reports, conclusions or recommendations. MorphoSys assumes no liability for the accuracy of such information and undertakes no obligation to update it if it is not aware of changes.


American Depositary Shares



Security Paper: American Depositary Shares (ADS)
Ratio: 4 ADSs = 1 ordinary share
U.S. Security Code (Cusip): 617760202
Trading Symbol: MOR
Depositary Bank: The Bank of New York
Local Custodian Bank: The Bank of New York Mellon SANV

ADS administration

All enquiries on ADS holdings should be made to:

BNY Mellon Shareowner Services
PO Box 505000
Louisville, KY 40233-5000
Phone: +1 201 680 6825
Toll free (in the US): +1-888-BNY-ADRS (+1-888-269-2377)

Share Buy-Back

Share Buy-Back March 2016

The Management Board of MorphoSys AG announced on February 24, 2016 with the approval of the Supervisory Board the decision to repurchase its own shares over the stock market for a total purchase price of up to EUR 2.18 million (excluding ancillary costs). The share buy-back will take place between March 3 and March 10, 2016, and is based on the authorization of the Annual General Meeting on May 23, 2014. On the basis of the current share price (EUR 37.47; Xetra closing price as of February 23, 2016), the total purchasing volume amounts to up to 58,179 shares or 0.22% of the registered share capital of the Company.

The Company intends to use the shares for its long-term incentive programs for its Executive Board and the Senior Management Group, but the shares can also be used for all other legally permitted purposes stated in the authorization of the Annual General Meeting of 2014.

The relevant conditions of the shareholders' resolution passed in the Annual General Meeting 2014 on the authorization to acquire and to use its own shares shall apply. The purchase price paid per share may not be more than 10% higher or 20% lower than the Company's share price determined by the opening auction in the Xetra trading system on the day of trading.

The share buy-back has been handled independently of and uninfluenced by the Company through an appointed bank in compliance with the safe-harbor provisions.

The share buy-back program in 2016 was completed on March 4th. Thereby 52,295 shares in total were acquired.


Overview Share Buy-Back Program March 2016

Date Number of Shares Average Price in € Purchased Volume in €
March 3, 2016 13,043 42.483 554,105.77
March 4, 2016 39,252 41.421 1,625,857.09
Total 52,295 41.686 2,179,962.86